APP and Alzheimer disease: In the Tg19959 AD model mice, which harbors the human amyloid precursor protein with two mutations, administration of CDDO-methylamide (CDDO-MA) notably enhances spatial memory retention and decreases plaque accumulation, Aβ42 levels, microgliosis, and oxidative stress [102].